
Sign up to save your podcasts
Or


Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.
By Modern Optometry5
1515 ratings
Leslie O’Dell, OD, FAAO, and Jackie Garlich, OD, FAAO, welcome Tom Kislan, OD, to discuss Tyrvaya (Oyster Point Pharma)—an FDA-approved nasal spray for dry eye treatment. Together, they discuss the link between neural stimulation and basal tear production, patient selection for Tyrvaya, patient education on product use within the clinic, and more.

75 Listeners

1,145 Listeners

9,231 Listeners

7,995 Listeners

63 Listeners

79 Listeners

520 Listeners

5 Listeners

18 Listeners

20 Listeners

817 Listeners

21 Listeners

354 Listeners

20 Listeners

18 Listeners